Natixis Advisors LLC Acquires 101,167 Shares of GE HealthCare Technologies Inc. $GEHC

Natixis Advisors LLC raised its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 21.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 568,481 shares of the company’s stock after buying an additional 101,167 shares during the quarter. Natixis Advisors LLC owned about 0.12% of GE HealthCare Technologies worth $42,693,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of GEHC. True North Advisors LLC boosted its position in shares of GE HealthCare Technologies by 2.0% during the third quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock worth $525,000 after acquiring an additional 139 shares during the last quarter. Klingman & Associates LLC increased its holdings in GE HealthCare Technologies by 4.0% in the 3rd quarter. Klingman & Associates LLC now owns 3,634 shares of the company’s stock valued at $273,000 after acquiring an additional 139 shares during the last quarter. Colonial Trust Advisors lifted its stake in GE HealthCare Technologies by 11.1% in the 3rd quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock worth $104,000 after purchasing an additional 139 shares in the last quarter. Exchange Traded Concepts LLC lifted its stake in GE HealthCare Technologies by 1.3% in the 3rd quarter. Exchange Traded Concepts LLC now owns 11,490 shares of the company’s stock worth $863,000 after purchasing an additional 150 shares in the last quarter. Finally, Modera Wealth Management LLC boosted its holdings in shares of GE HealthCare Technologies by 3.5% during the 2nd quarter. Modera Wealth Management LLC now owns 4,500 shares of the company’s stock valued at $333,000 after purchasing an additional 152 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on GEHC. Stifel Nicolaus lifted their target price on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a report on Wednesday, February 4th. Piper Sandler increased their price target on GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a research note on Friday, January 30th. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. Citigroup lifted their price objective on GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. Finally, UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and upped their price objective for the stock from $73.00 to $77.00 in a report on Thursday, January 15th. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, GE HealthCare Technologies has an average rating of “Hold” and a consensus price target of $92.50.

GE HealthCare Technologies Price Performance

Shares of GEHC stock opened at $75.63 on Tuesday. The stock has a 50 day moving average price of $81.66 and a 200 day moving average price of $78.62. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $89.77. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. The firm has a market capitalization of $34.47 billion, a P/E ratio of 16.59, a P/E/G ratio of 1.63 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The company had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. During the same quarter in the prior year, the company posted $1.45 EPS. GE HealthCare Technologies’s quarterly revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be issued a dividend of $0.035 per share. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.07%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.